Sabine D. Brookman-May: Excellent Review on PSMA PET for Prostate Cancer Diagnosis
Sabine D. Brookman-May, Senior Vice President of Therapeutic Area and Head of Urologic Oncology at Aura Biosciences, shared a post on X by European Urology, adding:
“Excellent comprehensive review and meta-analysis on the diagnostic role of PSMA PET in Prostate Cancer
High diagnostic value of PSMA PET, especially when combined with MRI
NPV indicates limitations to guide LND – not enough to omit biopsy.”
Quoting European Urology’s post:
“New in European Urology!
PSMA PET for Prostate Cancer Diagnosis and Staging by Elio Mazzone et al.
This comprehensive meta-analysis confirms the high diagnostic value of PSMA PET – especially when combined with MRI – but reminds us it’s not enough to skip biopsy or lymph node dissection.”
Title: A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment
Authors: Elio Mazzone, Donato Cannoletta, Leonardo Quarta, David C. Chen, Alice Thomson, Francesco Barletta, Armando Stabile, Daniel Moon, Renu Eapen, Nathan Lawrentschuk, Francesco Montorsi, Shankar Siva, Michael S. Hofman, Arturo Chiti, Declan G. Murphy, Alberto Briganti, Marlon L. Perera
You can read the Full Article in European Urology.
More posts featuring Sabine D. Brookman-May.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023